10-60267226-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020987.5(ANK3):​c.513+2905G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.458 in 151,860 control chromosomes in the GnomAD database, including 16,392 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.46 ( 16392 hom., cov: 32)

Consequence

ANK3
NM_020987.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.286

Publications

1 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.625 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_020987.5 linkc.513+2905G>C intron_variant Intron 5 of 43 ENST00000280772.7 NP_066267.2
ANK3NM_001204404.2 linkc.462+2905G>C intron_variant Intron 5 of 43 NP_001191333.1
ANK3NM_001320874.2 linkc.513+2905G>C intron_variant Intron 5 of 42 NP_001307803.1
ANK3NM_001204403.2 linkc.495+2905G>C intron_variant Intron 6 of 43 NP_001191332.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000280772.7 linkc.513+2905G>C intron_variant Intron 5 of 43 1 NM_020987.5 ENSP00000280772.1

Frequencies

GnomAD3 genomes
AF:
0.458
AC:
69572
AN:
151744
Hom.:
16389
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.362
Gnomad AMI
AF:
0.350
Gnomad AMR
AF:
0.512
Gnomad ASJ
AF:
0.440
Gnomad EAS
AF:
0.644
Gnomad SAS
AF:
0.564
Gnomad FIN
AF:
0.497
Gnomad MID
AF:
0.516
Gnomad NFE
AF:
0.480
Gnomad OTH
AF:
0.470
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.458
AC:
69597
AN:
151860
Hom.:
16392
Cov.:
32
AF XY:
0.463
AC XY:
34341
AN XY:
74222
show subpopulations
African (AFR)
AF:
0.362
AC:
14968
AN:
41404
American (AMR)
AF:
0.512
AC:
7817
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.440
AC:
1525
AN:
3468
East Asian (EAS)
AF:
0.643
AC:
3309
AN:
5148
South Asian (SAS)
AF:
0.563
AC:
2711
AN:
4816
European-Finnish (FIN)
AF:
0.497
AC:
5233
AN:
10520
Middle Eastern (MID)
AF:
0.514
AC:
150
AN:
292
European-Non Finnish (NFE)
AF:
0.479
AC:
32563
AN:
67918
Other (OTH)
AF:
0.474
AC:
1002
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1894
3788
5683
7577
9471
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
640
1280
1920
2560
3200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.318
Hom.:
799
Bravo
AF:
0.453
Asia WGS
AF:
0.572
AC:
1981
AN:
3466

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.7
DANN
Benign
0.67
PhyloP100
0.29
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10761471; hg19: chr10-62026984; API